Related Experiment Video

Updated: May 7, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

PPARγ against tumors by different signaling pathways

Zhi Zhang1, Ying Xu, Qinggang Xu

  • 1Institute of Life Sciences, Jiangsu University, Zhenjiang, PR China.

Onkologie
|October 11, 2013
PubMed

Insights

Peroxisome proliferator-activated receptor-gamma (PPARγ) regulates crucial cellular processes and shows potential as a cancer therapeutic target. This review explores how PPARγ and its ligands influence tumorigenesis through various pathways.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Peroxisome proliferator-activated receptor-gamma (PPARγ) is a nuclear hormone receptor superfamily member.
  • PPARγ is expressed in multiple tissues including adipose tissue, liver, and lung.
  • It plays a key role in regulating inflammation, adipocyte differentiation, glucose homeostasis, and tumorigenesis.

Purpose of the Study:

  • To review the role of PPARγ in cancer.
  • To elucidate the mechanisms by which PPARγ and its ligands regulate tumorigenesis.
  • To highlight PPARγ as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of existing research on PPARγ and cancer.
  • Analysis of various pathways influenced by PPARγ and its ligands.
  • Synthesis of evidence regarding PPARγ's role in tumor suppression and promotion.

Main Results:

  • PPARγ is implicated in both tumor suppression and promotion, depending on the context.
  • Ligands of PPARγ can modulate its activity and influence cancer progression.
  • Multiple signaling pathways are involved in PPARγ-mediated regulation of tumorigenesis.

Conclusions:

  • PPARγ represents a promising target for novel cancer therapies.
  • Understanding the complex mechanisms of PPARγ in tumorigenesis is crucial for therapeutic development.
  • Further research is needed to fully harness the anti-cancer potential of PPARγ and its ligands.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K